CRED SMPC 2024

Critical information

• Name of drug (followed by common name if product has invented name)

• Strength

• Route of administration

• Posology

• Warnings

29

29

General considerations for all packs

•

Large font

• Name on three non-opposing faces of the pack

• Common name should be given due prominence

•

Innovative pack design

30

30

15